Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Oct 15, 2017; 9(10): 407-415
Published online Oct 15, 2017. doi: 10.4251/wjgo.v9.i10.407
Published online Oct 15, 2017. doi: 10.4251/wjgo.v9.i10.407
Study (Institution, author, yr) | n | Median survival, mo | |||
Pancreatic cancer | Ampullary cancer | Biliary cancer | Duodenal cancer | ||
Johns Hopkins, United States He et al[14], 2014 | 2564 | 19 | 47 | 23 | 54 |
Academic Medical Centre, The Netherlands Tol et al[8], 2015 | 760 | 19 | 36 | 29 | Not reached |
Taipei Veterans General Hospital, Taiwan Chen et al[15], 2013 | 501 | 13.7 | 28.9 | 24.4 | 21.7 |
Ohio State University, United States Hatzaras et al[24], 2010 | 346 | 17.1 | 44.3 | 17.9 | N/I |
Queen Elizabeth Hospital, Birmingham, United Kingdom Jarufe et al[28], 2004 | 251 | 13.4 | 35.5 | 16 | N/I |
- Citation: Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, Merrett ND. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer. World J Gastrointest Oncol 2017; 9(10): 407-415
- URL: https://www.wjgnet.com/1948-5204/full/v9/i10/407.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i10.407